ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736201 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736201; 2) Community: the network communities that were significantly associated with the response to NSC 736201; 3) Molecule: the relationships between components within communities and NSC 736201; 4) MDR: the compounds that were significantly associated with the NSC 736201.

NSC Compound Enrichment Correlation
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0186186224062459 0.034919433
NSC 717468 Null 0.0186186224062459 0.079568793
NSC 720495 Null 0.0186186224062459 0.10697235
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0186186224062459 0.67128902
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0186186224062459 0.2957914
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.0186186224062459 0.71874679
NSC 109834 Null 0.0220039422291538 0.29487422
NSC 119875 Cisplatin 0.0220039422291538 0.63282611
NSC 176507 Fastigilin C 0.0220039422291538 0.18182258
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0220039422291538 0.63516089
Total:108  Current:57    [First] [Prev] [Next] [Last]